CVS Health (CVS) Tops Q1 EPS by 7c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $93.87 -0.93%
EPS Growth %: +3.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: +3.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.22, $0.07 better than the analyst estimate of $2.15. Revenue for the quarter came in at $76.8 billion versus the consensus estimate of $75.39 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.20-$8.40, versus the consensus of $8.27.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Teledyne Technologies (TDY) Tops Q3 EPS by 56c, Beats on Revenue; Offers FY26 EPS Guidance
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
